Universität zu Köln

Journal Article

Baues, Christian, Trommer-Nestler, Maike, Jablonska, Karolina, Broeckelmann, Paul J., Schlaak, Max, von Bergwelt-Baildon, Michael, Engert, Andreas, Semrau, Robert, Marnitz, Simone and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2017). Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy, 9 (5). S. 423 - 434. LONDON: FUTURE MEDICINE LTD. ISSN 1750-7448

Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Angelopoulou, Maria K. and Vassilakopoulos, Theodoros P. (2016). Prognostic factors in Hodgkin lymphoma. Semin. Hematol., 53 (3). S. 155 - 165. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

Broeckelmann, Paul J., Borchmann, Peter and Engert, Andreas (2016). Current and future immunotherapeutic approaches in Hodgkin lymphoma. Leuk. Lymphoma, 57 (9). S. 2014 - 2025. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Broeckelmann, Paul J., Eichenauer, Dennis A., Jakob, Tina, Follmann, Markus ORCID: 0000-0003-3790-5578, Engert, Andreas and Skoetz, Nicole (2018). Hodgkin Lymphoma in Adults. Dtsch. Arztebl. Int., 115 (31-32). S. 535 - 546. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452

Broeckelmann, Paul J. and Engert, Andreas (2017). Checkpoint Inhibition in Hodgkin Lymphoma - a Review. Oncol. Res. Treat., 40 (11). S. 654 - 660. BASEL: KARGER. ISSN 2296-5262

Broeckelmann, Paul J., Goergen, Helen, Kohnhorst, Charlotte, Von Tresckow, Bastian, Moccia, Alden, Markova, Jana, Meissner, Julia, Kerkhoff, Andrea, Ludwig, Wolf-Dieter, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2017). Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. J. Clin. Oncol., 35 (13). S. 1444 - 1455. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Broeckelmann, Paul J., McMullen, Suzanne, Ben Wilson, J., Mueller, Kerstin, Goring, Sarah, Stamatoullas, Aspasia, Zagadailov, Erin, Gautam, Ashish, Huebner, Dirk, Dalal, Mehul and Illidge, Tim (2019). Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom. Br. J. Haematol., 184 (2). S. 202 - 215. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., Sasse, Stephanie and Engert, Andreas (2018). Balancing risk and benefit in early-stage classical Hodgkin lymphoma. Blood, 131 (15). S. 1666 - 1679. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Zagadailov, Erin A., Corman, Shelby L., Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R. and Illidge, Tim (2017). Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. Eur. J. Haematol., 99 (6). S. 553 - 559. HOBOKEN: WILEY. ISSN 1600-0609

Broeckelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2018). Relapsed or refractory classical Hodgkin's lymphoma. Novel therapeutic approaches. Onkologe, 24 (4). S. 322 - 329. NEW YORK: SPRINGER. ISSN 1433-0415

Cheah, Chan Y., Broeckelmann, Paul J., Chihara, Dai ORCID: 0000-0002-1153-2294, Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec C., Augustson, Bradley, Vose, Julie, Bartlett, Nancy L., Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina, Oki, Yasuhiro and Fanale, Michelle A. (2016). Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Am. J. Hematol., 91 (9). S. 894 - 900. HOBOKEN: WILEY. ISSN 1096-8652

Hude, Ida, Sasse, Stephanie, Broeckelmann, Paul J., von Tresckow, Bastian, Momotow, Jesko, Engert, Andreas and Borchmann, Sven (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. Br. J. Haematol., 181 (6). S. 837 - 841. HOBOKEN: WILEY. ISSN 1365-2141

Hude, Ida, Sasse, Stephanie, Engert, Andreas and Broeckelmann, Paul J. (2017). The emerging role of immune checkpoint inhibition in malignant lymphoma. Haematologica, 102 (1). S. 30 - 43. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Zagadailov, Erin A., Corman, Shelby, Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R., Broeckelmann, Paul J. and Illidge, Tim (2018). Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany. Leuk. Lymphoma, 59 (6). S. 1413 - 1420. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403